The Harvard Program in Therapeutic Science (HiTS) is rethinking the basic and clinical science needed to discover, develop and deliver better drugs. Investigators from Harvard and other universities, Harvard Medical School (HMS) and HMS-affiliated hospitals will combine experiments and computation in a systems approach to modeling therapeutic and toxic drug responses. Such models aim to reduce expensive failures in testing new drugs and realize the promise of personalized medicine at a cost society can afford.  READ MORE